Latest News Releases

PTA-Adhoc: Biofrontera AG: CHANGES IN THE SUPERVISORY BOARD

Public disclosure of inside information according to article 17 MAR

Leverkusen, Germany (pta021/06.05.2024/16:50) - Mr. Wilhelm K. T. Zours has informed Biofrontera AG in a statement dated today that he is resigning from his office as member and Chairman of the Supervisory Board for important personal reasons with immediate effect.

The Deputy Chairman of the Supervisory Board, Dr. Jörgen Tielmann, will perform his duties on an interim basis until a new Chairman is appointed.

(end)

emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor Relations
phone: +49 (0) 214 87 63 20
e-mail: ir@biofrontera.com
website: www.biofrontera.com

ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Dusseldorf, Frankfurt; free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate

[ source: https://www.pressetext.com/news/20240506021 ]

Biofrontera AG – an attractive investment

We are experts in photodynamic therapy. With our innovative products and treatment methods, we make our contribution to skin health and at the same time create value for our investors.

Biofrontera is listed on the Frankfurt Stock Exchange (B8FK).